Brooks O'Neil
Stock Analyst at Lake Street
(1.08)
# 3,670
Out of 4,873 analysts
36
Total ratings
29.41%
Success rate
-16.97%
Average return
Main Sectors:
Stocks Rated by Brooks O'Neil
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| PIII P3 Health Partners | Maintains: Buy | $50 → $20 | $6.07 | +229.49% | 2 | Apr 21, 2025 | |
| SRDX Surmodics | Upgrades: Buy | $43 | $28.76 | +49.54% | 4 | Mar 7, 2025 | |
| LMAT LeMaitre Vascular | Maintains: Buy | $105 → $110 | $84.54 | +30.12% | 2 | Feb 28, 2025 | |
| BBNX Beta Bionics | Initiates: Buy | $30 | $14.77 | +103.11% | 1 | Feb 24, 2025 | |
| SMLR Semler Scientific | Maintains: Buy | $40 → $71 | $41.04 | +73.00% | 1 | Jan 24, 2025 | |
| MODV ModivCare | Maintains: Buy | $30 → $10 | $3.44 | +190.70% | 3 | Jan 13, 2025 | |
| RCEL AVITA Medical | Maintains: Buy | $20 → $14 | $4.77 | +193.50% | 6 | Jan 8, 2025 | |
| LFVN LifeVantage | Initiates: Buy | $26 | $12.56 | +107.01% | 1 | Dec 19, 2024 | |
| LFMD LifeMD | Initiates: Buy | $12 | $12.84 | -6.54% | 1 | Dec 10, 2024 | |
| HROW Harrow | Maintains: Buy | $45 → $55 | $31.55 | +74.33% | 3 | Oct 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $32 → $18 | $11.25 | +60.07% | 4 | Sep 3, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $5 | $3.54 | +41.24% | 1 | Jun 28, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $60 → $75 | $19.42 | +286.20% | 1 | May 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $12 | $5.96 | +101.34% | 1 | Mar 7, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $20 → $26 | $21.83 | +19.10% | 2 | Feb 15, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $45 | $5.18 | +768.73% | 1 | Nov 21, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $11 | $0.81 | +1,264.43% | 1 | Apr 8, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $128 | $33.00 | +286.36% | 1 | Sep 15, 2020 |
P3 Health Partners
Apr 21, 2025
Maintains: Buy
Price Target: $50 → $20
Current: $6.07
Upside: +229.49%
Surmodics
Mar 7, 2025
Upgrades: Buy
Price Target: $43
Current: $28.76
Upside: +49.54%
LeMaitre Vascular
Feb 28, 2025
Maintains: Buy
Price Target: $105 → $110
Current: $84.54
Upside: +30.12%
Beta Bionics
Feb 24, 2025
Initiates: Buy
Price Target: $30
Current: $14.77
Upside: +103.11%
Semler Scientific
Jan 24, 2025
Maintains: Buy
Price Target: $40 → $71
Current: $41.04
Upside: +73.00%
ModivCare
Jan 13, 2025
Maintains: Buy
Price Target: $30 → $10
Current: $3.44
Upside: +190.70%
AVITA Medical
Jan 8, 2025
Maintains: Buy
Price Target: $20 → $14
Current: $4.77
Upside: +193.50%
LifeVantage
Dec 19, 2024
Initiates: Buy
Price Target: $26
Current: $12.56
Upside: +107.01%
LifeMD
Dec 10, 2024
Initiates: Buy
Price Target: $12
Current: $12.84
Upside: -6.54%
Harrow
Oct 4, 2024
Maintains: Buy
Price Target: $45 → $55
Current: $31.55
Upside: +74.33%
Sep 3, 2024
Maintains: Buy
Price Target: $32 → $18
Current: $11.25
Upside: +60.07%
Jun 28, 2024
Initiates: Buy
Price Target: $5
Current: $3.54
Upside: +41.24%
May 22, 2024
Maintains: Buy
Price Target: $60 → $75
Current: $19.42
Upside: +286.20%
Mar 7, 2024
Initiates: Buy
Price Target: $12
Current: $5.96
Upside: +101.34%
Feb 15, 2023
Maintains: Buy
Price Target: $20 → $26
Current: $21.83
Upside: +19.10%
Nov 21, 2022
Assumes: Buy
Price Target: $45
Current: $5.18
Upside: +768.73%
Apr 8, 2022
Initiates: Buy
Price Target: $11
Current: $0.81
Upside: +1,264.43%
Sep 15, 2020
Initiates: Buy
Price Target: $128
Current: $33.00
Upside: +286.36%